High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements

Clinical trials for High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements explained in plain language.

Never miss a new study

Get alerted when new High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements trials appear

Sign up with your email to follow new studies for High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 2

New Two-Step attack on aggressive lymphoma shows promise in early trial

Disease control Recruiting now

This phase 2 trial is testing whether a targeted antibody-drug combination (loncastuximab tesirine plus rituximab) followed by standard chemotherapy can improve outcomes for people with high-risk diffuse large B-cell lymphoma. The study enrolls 24 adults with untreated double-exp…

Matched conditions: HIGH GRADE B-CELL LYMPHOMA WITH MYC, BCL2, AND BCL6 REARRANGEMENTS

Phase 2 • Sponsor: University of California, Davis • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements

Get alerted when new High grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements trials appear

New Two-Step attack on aggressive lymphoma shows promise in early trial